- Home
- IMOS vs ZLAB Comparison
IMOS vs ZLAB Comparison
Compare IMOS & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IMOS | ZLAB |
|---|---|---|
| Founded | 1997 | 2013 |
| Country | Taiwan | China |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.6B |
| IPO Year | 2007 | 2017 |
Fundamental Metrics
Financial Performance| Metric | IMOS | ZLAB |
|---|---|---|
| Price | $77.76 | $25.49 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 12 |
| Target Price | N/A | ★ $33.14 |
| AVG Volume (30 Days) | 69.7K | ★ 713.1K |
| Earning Date | 11-10-2026 | 11-05-2026 |
| Dividend Yield | ★ 0.89% | N/A |
| EPS Growth | N/A | ★ 38.46 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $460,156,000.00 |
| Revenue This Year | $29.61 | N/A |
| Revenue Next Year | $18.30 | $26.50 |
| P/E Ratio | $158.35 | ★ N/A |
| Revenue Growth | N/A | ★ 15.33 |
| 52 Week Low | $19.24 | $15.96 |
| 52 Week High | $78.35 | $33.97 |
Technical Indicators
Market Signals| Indicator | IMOS | ZLAB |
|---|---|---|
| Relative Strength Index (RSI) | 73.68 | 51.50 |
| Support Level | $53.64 | $24.81 |
| Resistance Level | $78.35 | $27.20 |
| Average True Range (ATR) | 1.99 | 0.87 |
| MACD | 1.42 | -0.10 |
| Stochastic Oscillator | 89.32 | 41.28 |
Price Performance
Historical ComparisonAbout IMOS ChipMOS TECHNOLOGIES INC.
ChipMOS TECHNOLOGIES Inc is engaged in the research, development, manufacturing, and sale of high-integration and high-precision integrated circuits and related assembly and testing services. The company's segments include Testing, Assembly, Testing, and Assembly for LCD, OLED, and other Display Panel Driver Semiconductors (LCDD), Bumping, and others. It derives a majority of its revenue from Taiwan followed by Japan, the People's Republic of China, Singapore, and others.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.